AMED Insider Trading
Insider Ownership Percentage: 2.10%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
Amedisys Share Price & Price History
Current Price: $94.69
Price Change: ▲ Price Increase of +0.19 (0.20%)
As of 04/28/2025 05:00 PM ET
Amedisys Insider Trading History
Amedisys Institutional Trading History
Data available starting January 2016
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
Read More on Amedisys
Today's Range
Now: $94.69
52 Week Range
Now: $94.69
Volume
295,185 shs
Average Volume
404,561 shs
Market Capitalization
$3.11 billion
P/E Ratio
37.58
Dividend Yield
N/A
Beta
0.89
Who are the major institutional investors of Amedisys?
Amedisys' top institutional investors include:
- CIBRA Capital Ltd — 0.66%
- Principal Financial Group Inc. — 0.23%
- SG Americas Securities LLC — 0.17%
- Bridge City Capital LLC — 0.11%
- New York State Teachers Retirement System — 0.08%
- Amalgamated Bank — 0.05%
Learn More about top institutional investors of Amedisys stock.
Which major investors are selling Amedisys stock?
In the last quarter, AMED stock was sold by these institutional investors:
- Cannon Global Investment Management LLC
- New York State Teachers Retirement System
- SG Americas Securities LLC
- Amalgamated Bank
- Yousif Capital Management LLC
- KBC Group NV
Which major investors are buying Amedisys stock?
Within the last quarter, AMED stock was acquired by institutional investors including:
- CIBRA Capital Ltd
- Wealthquest Corp
- Teacher Retirement System of Texas
- Parallel Advisors LLC
- FNY Investment Advisers LLC
- GAMMA Investing LLC
- Versant Capital Management Inc
- Exchange Traded Concepts LLC